Phibro Animal Health Corporatio (PAHC) Financials
PAHC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 972.7 million | 701.9 million |
| 2023-09-30 | 964.5 million | 691.5 million |
| 2023-06-30 | 971.4 million | 688.9 million |
| 2023-03-31 | 965.4 million | 693.1 million |
PAHC Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 20.6 million | 80000 |
| 2023-09-30 | 8.7 million | 81000 |
| 2023-06-30 | 9.3 million | -5.4 million |
| 2023-03-31 | -1.6 million | ? |
PAHC Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 1.3 million |
| 2023-09-30 | -8.0 million |
| 2023-06-30 | 11.5 million |
| 2023-03-31 | 10.0 million |
PAHC Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 92.5 million | - | 38.2 million |
| 2023-09-30 | 91.2 million | - | 35.5 million |
| 2023-06-30 | 81.3 million | 452.5 million | 35.1 million |
| 2023-03-31 | 77.2 million | 466.0 million | 36.3 million |
PAHC Shares Outstanding
PAHC Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 11.0 million | - | 62.9 million | - |
| 2023-09-30 | 7.5 million | - | 68.5 million | - |
| 2023-06-30 | 10.9 million | 24.4 million | 52.9 million | - |
| 2023-03-31 | 7.9 million | - | 57.0 million | - |
PAHC Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 249.9 million | 171.3 million |
| 2023-09-30 | 231.3 million | 163.6 million |
| 2023-06-30 | 255.0 million | 178.4 million |
| 2023-03-31 | 245.7 million | 170.1 million |
PAHC
Price: $13.61
Dividend Yield: 0.04%
Forward Dividend Yield: 3.53%
Payout Ratio: 129.73%
Dividend Per Share: 0.48 USD
Earnings Per Share: 0.37 USD
P/E Ratio: 32.54
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 51500
Ebitda: 30.9 millionMarket Capitalization: 523.7 million
Average Dividend Frequency: 4
Years Paying Dividends: 11
DGR5: 3.82%